Instrument Inactif

Communiqués Trillium Therapeutics

Actions

TRIL

CA89620X5064

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Trillium Therapeutics : Pfizer Completes Acquisition of Trillium Therapeutics - Form 8-K	17/11/21	PU
TRILLIUM THERAPEUTICS INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	17/11/21	AQ
TRILLIUM THERAPEUTICS INC. : Other Events (form 8-K)	16/11/21	AQ
Trillium: Q3 Earnings Snapshot	12/11/21	AQ
TRILLIUM THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	12/11/21	AQ
Trillium Therapeutics Receives Final Court Order Approving Arrangement - Form 8-K	29/10/21	PU
TRILLIUM THERAPEUTICS INC. : Other Events, Financial Statements and Exhibits (form 8-K)	29/10/21	AQ
Trillium Therapeutics Receives Final Court Order Approving Arrangement	28/10/21	GL
Trillium Securityholders Approve Acquisition by Pfizer - Form 8-K	27/10/21	PU
TRILLIUM THERAPEUTICS INC. : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	27/10/21	AQ
Trillium Securityholders Approve Acquisition by Pfizer	26/10/21	AQ
Trillium Therapeutics : Material Event - Form 8-K	20/10/21	PU
TRILLIUM THERAPEUTICS INC. : Other Events (form 8-K)	20/10/21	AQ
TRILLIUM THERAPEUTICS INC. : Other Events (form 8-K)	15/10/21	AQ
TRILLIUM THERAPEUTICS INC. : Other Events (form 8-K)	13/10/21	AQ
S&P Dow Jones Indices Announces Changes to the S&P/TSX Composite Index	03/09/21	AQ
TRILLIUM THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Trillium Therapeutics Inc. - TRIL	24/08/21	BU
Trillium, Analog Devices rise: General Motors, Lennar fall	23/08/21	AQ
Trillium Therapeutics : Pfizer signs deal to buy Trillium Therapeutics for US$2.26 billion	23/08/21	AQ
Pfizer : to pay $2.26B for cancer treatment developer Trillium	23/08/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Trillium Therapeutics

Actions

TRIL

CA89620X5064

Communiqués

Filtres